«There are currently no drug
therapies available that improve the very limited natural recovery from spinal cord injuries that patients experience,» said Lyn Jakeman, Ph.D., a program director at the NIH's National Institute of Neurological Disorders and Stroke, Bethesda, MD. «This is a great step
towards identifying a
novel agent for helping people recover.»
By identifying
novel molecular targets and potential new drugs, this powerful technological structure will contribute significantly to groundbreaking research
towards the development of new anti-cancer
therapies.